A Study to Assess TTI-0102 vs Placebo in MELAS Patients

Clinical trial NCT06644534 · COMPLETED

Trial details

NCT number: NCT06644534
Sponsor: Thiogenesis Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

MELAS Syndrome Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like Episodes (MELAS)

Start date: 2025-05-12
Primary completion: 2026-01-12
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.